Procter & Gamble Hygiene & Health Care Ltd.
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Large-cap with βΉ40.1K Cr market capitalisation
Concerns0
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | β | β | β | β | β | β | β | β |
| Mar 2024 | βΉ4.21 K Cr | β | βΉ675.00 Cr | β | β | β | 7.4% | -0.4% |
| Mar 2023 | βΉ3.92 K Cr | β | βΉ678.00 Cr | β | β | β | 0.4% | 17.7% |
| Mar 2022 | βΉ3.90 K Cr | β | βΉ576.00 Cr | β | β | β | 9.1% | -11.7% |
| Mar 2021 | βΉ3.57 K Cr | β | βΉ652.00 Cr | β | β | β | 19.1% | 50.6% |
| Mar 2020 | βΉ3.00 K Cr | β | βΉ433.00 Cr | β | β | β | 1.9% | 3.3% |
| Mar 2019 | βΉ2.95 K Cr | β | βΉ419.00 Cr | β | β | β | 20.0% | 11.7% |
| Mar 2018 | βΉ2.46 K Cr | β | βΉ375.00 Cr | β | β | β | 5.8% | -13.4% |
| Mar 2017 | βΉ2.32 K Cr | β | βΉ433.00 Cr | β | β | β | 2.0% | 2.6% |
| Mar 2016 | βΉ2.27 K Cr | β | βΉ422.00 Cr | β | β | β | -2.5% | 22.0% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 4,341 |
| Total Expenses | 3,178 |
| EBIT / Operating Profit | 1,162 |
| OPM % | 27 |
| Other Income | 49 |
| Finance Costs | 12 |
| Depreciation & Amortisation | 38 |
| Profit Before Tax | 1,161 |
| Tax % | - |
| Net Profit / PAT | 859 |
| EPS (βΉ) | 264.78 |
| Dividend Payout % | - |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Procter & Gamble Hygiene & Health Care Ltd.this co. | βΉ40.12 K Cr | βΉ3.37 K Cr | 48.50 | 43.15 | 0.00 | -19.8% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |